miR-200b is involved in intestinal fibrosis of Crohn’s disease
Authors:
Open Access
- 23 January 2012
- journal article
- Published by Spandidos Publications in International Journal of Molecular Medicine
- Vol. 29 (4) , 601-606
Abstract
Intestinal fibrosis is one of the major serious complications of Crohn's disease (CD). However, there are no effective antifibrotic drugs to treat intestinal fibrosis in CD. Therefore, it is important to understand the pathogenesis of fibrosis in CD. It has been reported that members of the miR-200 family are essential in the regulation of renal fibrogenesis. In this study, we analyzed the function of miR-200a and miR-200b in intestinal fibrosis, which was induced by transforming growth factor β1 (TGF-β1) in vitro. Furthermore, we detected the expression of miR-200a and miR-200b in CD specimens, which were divided into groups of fibrosis and no-fibrosis. The results of this study showed that administration of miR-200b could partially protect intestinal epithelial cells from fibrogenesis in vitro. Furthermore, we found that miR-200b was overexpressed in the serum of the fibrosis group. The results suggest that miR-200b has potential value for diagnostic and therapeutic applications for CD patients with fibrosis complications.Keywords
This publication has 41 references indexed in Scilit:
- miR-200b Precursor Can Ameliorate Renal Tubulointerstitial FibrosisPLOS ONE, 2010
- TGF-β-induced epithelial to mesenchymal transitionCell Research, 2009
- Glycoproteomic analysis of two mouse mammary cell lines during transforming growth factor (TGF)-beta induced epithelial to mesenchymal transitionProteome Science, 2009
- Intestinal fibrosis in inflammatory bowel disease — Current knowledge and future perspectivesJournal of Crohn's and Colitis, 2008
- Intestinal fibrosis in inflammatory bowel disease: progress in basic and clinical scienceCurrent Opinion in Gastroenterology, 2008
- The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1Nature Cell Biology, 2008
- A Switch from E-Cadherin to N-Cadherin Expression Indicates Epithelial to Mesenchymal Transition and Is of Strong and Independent Importance for the Progress of Prostate CancerClinical Cancer Research, 2007
- Cell size and invasion in TGF-β–induced epithelial to mesenchymal transition is regulated by activation of the mTOR pathwayJournal of Cell Biology, 2007
- Smad3 is key to TGF-β-mediated epithelial-to-mesenchymal transition, fibrosis, tumor suppression and metastasisCytokine & Growth Factor Reviews, 2006
- Fibrogenesis IV. Fibrosis and inflammatory bowel disease: cellular mediators and animal modelsAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2000